Category Archives: Pr Newswire

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., Aug. 09, 2024 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to four new employees. Fulcrum granted stock options to purchase shares of the […]

Belite Bio Reports Second Quarter 2024 Financial Results and Provides a Corporate Update

Tinlarebant, a novel oral therapy, is intended to slow disease progression in patients affected with Stargardt Disease (STGD1) and Geographic Atrophy (GA) in advanced Dry Age-related Macular Degeneration (Dry AMD) Phase 1b & 2/3 (“DRAGON II”) trial of Tinlarebant in adolescent STGD1 patients has been initiated and have completed enrollment for Phase 1b with six […]

SEG Solar Inaugurates Houston Module Plant and Rolls Out First Module

HOUSTON, Aug. 10, 2024 /PRNewswire/ — On August 8, 2024, SEG Solar (SEG), a leading U.S. photovoltaic manufacturer, held a grand opening ceremony for its new PV manufacturing base in Houston, Texas, marking a new chapter in SEG’s commitment to U.S. domestic manufacturing. During the ceremony, the first 585W YUKON N series module rolled off the […]

GenScript Biotech Reports First Half 2024 Results

Strong Revenue Growth and Strategic Advances Across Key Segments, Enhances Commitment to ESG and Sustainable Development  Impressive Financial Growth: The group reported a 43.5% increase in revenue, driven by a 156% boost in cell therapy revenue and a 75.4% rise in gross profit, showcasing strong performance across key segments. Focused on Innovation and Efficiency: Investing […]

i2 increases investment in intelligence analysis software to strengthen agencies’ pursuit of ‘bad actors’

LONDON and NEW YORK, Aug. 9, 2024 /PRNewswire/ — Today, i2 Group said increasing demand for its intelligence analytics software among NATO forces and intelligence and law enforcement agencies was driving the company’s double-digit growth.   The global leader in visual data analysis today reported an annual 18% uptick in software license sales and 10% workforce growth as […]

Global IBO Group Ltd., an Integrated AIGC Animation Platform Provider, Announce Definitive Business Combination Agreement With Bukit Jalil Global Acquisition 1 Ltd.

NEW YORK, Aug. 9, 2024 /PRNewswire/ — Global IBO Group Ltd. (“GIBO”), a unique and integrated AIGC animation creation and streaming platform for storytellers and content creators, and Bukit Jalil Global Acquisition 1 Ltd. (“Bukit Jalil Global”) (Nasdaq: BUJA), a publicly traded special purpose acquisition company, today announced that they have entered into a definitive […]

POWERCHINA Alleviates Harsh Summer Climate Change Conditions with Global Construction Projects

BEIJING, Aug. 9, 2024 /PRNewswire/ — Power Construction Corporation of China (“POWERCHINA” or “the Company”) continues to do its part to alleviate the harsh summer climate change challenges affecting many regions worldwide. The Company’s series of construction projects and actions have enhanced the flood control and drought resistance capabilities of various regions in Americas, Africa, and Asia, […]

Spectral Medical Announces Second Quarter Results and Provides Corporate Update

Tigris Trial Enrollment Reaches 126 Patients Strengthened Balance Sheet with Expected Funds to Complete Tigris Trial Enrollment TORONTO, Aug. 09, 2024 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its financial results for the second quarter ended […]

NeurAxis Reports Second Quarter 2024 Financial Results

Conference call will be held today, Friday, August 9 at 9:00 am ET Carmel, Ind., Aug. 09, 2024 (GLOBE NEWSWIRE) — NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced results for the second quarter period ended […]

Elucent Medical Announces Froedtert & the Medical College of Wisconsin Health Network to Provide New Breast Cancer Surgical Technology

EDEN PRAIRIE, Minn., Aug. 09, 2024 (GLOBE NEWSWIRE) — Elucent Medical, a pioneering medical technology company transforming the field of guided surgical technology, is thrilled to announce Froedtert & the Medical College of Wisconsin health network with the Elucent Medical advanced In-Body Spatial Intelligence (iSi) systems for breast cancer surgery. This new technology is expected […]